Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves’ Orbitopathy
Intravenous methylprednisolone (IVMP) pulse therapy is the first-line treatment for the active phase of moderate to severe Graves’ orbitopathy (GO). However, acute and severe liver damage has been reported during and after IVMP therapy. In this retrospective study, we investigated risk factors for l...
Saved in:
Main Authors: | Hiroyuki Eguchi, Junichi Tani, Saori Hirao, Munehisa Tsuruta, Ichiro Tokubuchi, Kentaro Yamada, Masataka Kasaoka, Yasuo Teshima, Tatsuyuki Kakuma, Yuji Hiromatsu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2015/835979 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influence of Methylprednisolone Pulse Therapy on Liver Function in Patients with Graves’ Orbitopathy
by: Piotr Miśkiewicz, et al.
Published: (2018-01-01) -
IgG4 as a Biomarker in Graves’ Orbitopathy
by: Michał Olejarz, et al.
Published: (2021-01-01) -
Therapeutic Effect of Gypenosides on Antioxidant Stress Injury in Orbital Fibroblasts of Graves’ Orbitopathy
by: Chao Ma, et al.
Published: (2022-01-01) -
Evaluation of IL-29 in Euthyroid Patients with Graves’ Orbitopathy: A Preliminary Study
by: Bogusz Falkowski, et al.
Published: (2020-01-01) -
Changes of plasma cytokines content in Graves’ orbitopathy patients, could be potential markers
by: Ying Fu, et al.
Published: (2024-04-01)